Intensity Therapeutics raises ~$1.9M net in $0.30/share public offering for clinical studies

INTENSITY THERAPEUTICS, INC.

Gross proceeds $2,002,500 from 6,675,000 shares at $0.30/share; underwriter exercised over-allotment for 1,001,250 additional shares.
Net proceeds ~$1.9M after underwriting discounts and expenses; offering closed June 13, 2025.
Representative's Warrants for 383,812 shares (5% of offering) issued at $0.375 exercise price, 5-year term.
Proceeds to fund INVINCIBLE-4 data readout (expected H1 2026) and continue INVINCIBLE-3 study maintenance.
ThinkEquity acted as sole book-running manager; shares traded on Nasdaq under INTS.

item 1.01item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.